Literature DB >> 8792587

Simulation of control strategies for the cattle tick Boophilus microplus employing vaccination with a recombinant Bm86 antigen preparation.

V Labarta1, M Rodríguez, M Penichet, R Lleonart, L L Luaces, J de la Fuente.   

Abstract

Current strategies for the control of the cattle tick Boophilus microplus include the use of chemicals as the principal control method. These methods, however, have met with partially successful results. The recent development of immunological methods for the control of the cattle tick has opened new possibilities for the design of control strategies. Employing the results obtained by us in experiments testing the effect of vaccination with the recombinant vaccine, Gavac (Heber Biotec S.A.), on tick populations, we have developed a model to evaluate, through a computer program, the efficacy of the vaccine as a control method. The action of the vaccine on the control of tick populations was simulated and the specific serum antibody titers required to decrease the tick population in the field were calculated. The specific serum antibody titer required to decrease the tick population in the field after the first vaccination scheme was found to be > or = 57,200 and the antibody titer required to maintain this effect when the vaccine is already acting and after successive revaccinations was found to be > or = 27,500. Considerations about revaccination schemes and combination between vaccination and acaricide treatments as possible control strategies are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792587     DOI: 10.1016/0304-4017(95)00855-1

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  7 in total

1.  Integrated control of acaricide-resistant Boophilus microplus populations on grazing cattle in Mexico using vaccination with Gavac and amidine treatments.

Authors:  M Redondo; H Fragoso; M Ortíz; C Montero; J Lona; J A Medellín; R Fría; V Hernández; R Franco; H Machado; M Rodríguez; J de la Fuente
Journal:  Exp Appl Acarol       Date:  1999-10       Impact factor: 2.132

2.  Evidence for the utility of the Bm86 antigen from Boophilus microplus in vaccination against other tick species.

Authors:  S de Vos; L Zeinstra; O Taoufik; P Willadsen; F Jongejan
Journal:  Exp Appl Acarol       Date:  2001       Impact factor: 2.132

3.  Genome wide scan for quantitative trait loci affecting tick resistance in cattle (Bos taurus x Bos indicus).

Authors:  Marco Antonio Machado; Ana Luisa S Azevedo; Roberto L Teodoro; Maria A Pires; Maria Gabriela C D Peixoto; Célio de Freitas; Márcia Cristina A Prata; John Furlong; Marcos Vinicius G B da Silva; Simone E F Guimarães; Luciana C A Regitano; Luiz L Coutinho; Gustavo Gasparin; Rui S Verneque
Journal:  BMC Genomics       Date:  2010-04-30       Impact factor: 3.969

4.  Experimental Infection of Calves with Transfected Attenuated Babesia bovis Expressing the Rhipicephalus microplus Bm86 Antigen and eGFP Marker: Preliminary Studies towards a Dual Anti-Tick/Babesia Vaccine.

Authors:  Monica L Mazuz; Jacob M Laughery; Benjamin Lebovitz; Daniel Yasur-Landau; Assael Rot; Reginaldo G Bastos; Nir Edery; Ludmila Fleiderovitz; Maayan Margalit Levi; Carlos E Suarez
Journal:  Pathogens       Date:  2021-01-29

5.  Efficacy of synergistic activity of seed oils from Carthamus tinctorius (Safflower) and Nasturtium officinale (Watercress) on the lethality of the cattle tick Hyalomma scupense (Acari: Ixodidae).

Authors:  Dhouha Alimi; Azhar Hajri; Selim Jallouli; Hichem Sebai
Journal:  Open Vet J       Date:  2022-02-02

6.  The Correlation between Subolesin-Reactive Epitopes and Vaccine Efficacy.

Authors:  Marinela Contreras; Paul D Kasaija; Fredrick Kabi; Swidiq Mugerwa; José De la Fuente
Journal:  Vaccines (Basel)       Date:  2022-08-16

7.  Inhibition of enzyme activity of Rhipicephalus (Boophilus) microplus triosephosphate isomerase and BME26 cell growth by monoclonal antibodies.

Authors:  Luiz Saramago; Mariana Franceschi; Carlos Logullo; Aoi Masuda; Itabajara da Silva Vaz; Sandra Estrazulas Farias; Jorge Moraes
Journal:  Int J Mol Sci       Date:  2012-10-12       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.